USE OF RECOMBINANT GANODERMA IMMUNOREGULATORY PROTEIN (RLZ-8) IN PREPARATION OF DRUG FOR TREATING MELANOMA

摘要

A use of recombinant ganoderma immunoregulatory protein (rLZ-8) in apreparation of a drug for treating melanoma is disclosed. By establishingexperimentalanimal models of orthotopic tumors and metastatic tumors, an anti-tumor effectof therLZ-8 is researched, which indicates that the rLZ-8 significantly inhibits agrowth ofthe orthotopic tumors of the melanoma and a formation of metastases of themelanoma.